Published in Cell Death Differ on December 01, 2001
Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes. Annu Rev Biochem (2009) 6.23
The DDB1-CUL4ADDB2 ubiquitin ligase is deficient in xeroderma pigmentosum group E and targets histone H2A at UV-damaged DNA sites. Proc Natl Acad Sci U S A (2006) 2.66
Ubp10/Dot4p regulates the persistence of ubiquitinated histone H2B: distinct roles in telomeric silencing and general chromatin. Mol Cell Biol (2005) 1.55
Cleavage and cytoplasmic relocalization of histone deacetylase 3 are important for apoptosis progression. Mol Cell Biol (2006) 1.46
MYRbase: analysis of genome-wide glycine myristoylation enlarges the functional spectrum of eukaryotic myristoylated proteins. Genome Biol (2004) 1.42
Solution structure of the Ubp-M BUZ domain, a highly specific protein module that recognizes the C-terminal tail of free ubiquitin. J Mol Biol (2007) 1.02
Breaking immunological tolerance in systemic lupus erythematosus. Front Immunol (2014) 0.94
Meiotic silencing and fragmentation of the male germline restricted chromosome in zebra finch. Chromosoma (2010) 0.86
Alterations of histone modifications by cobalt compounds. Carcinogenesis (2009) 0.86
"Cullin 4 makes its mark on chromatin". Cell Div (2006) 0.84
Deciphering histone 2A deubiquitination. Genome Biol (2008) 0.83
HDAC6 and Ubp-M BUZ domains recognize specific C-terminal sequences of proteins. Biochemistry (2010) 0.82
Altered dynamics of ubiquitin hybrid proteins during tumor cell apoptosis. Cell Death Dis (2012) 0.82
The Polycomb protein and E3 ubiquitin ligase Ring1B harbors an IRES in its highly conserved 5' UTR. PLoS One (2008) 0.79
Developmental downregulation of Xenopus cyclin E is phosphorylation and nuclear import dependent and is mediated by ubiquitination. Dev Biol (2011) 0.78
Histone modifications as regulators of life and death in Saccharomyces cerevisiae. Microb Cell (2015) 0.75
Human erythrocyte membrane glycoprotein: a re-evaluation of the molecular weight as determined by SDS polyacrylamide gel electrophoresis. Biochem Biophys Res Commun (1971) 5.18
Glycoproteins: isolation from cellmembranes with lithium diiodosalicylate. Science (1971) 4.92
The localization of Mg-Na-K-activated adenosine triphosphatase on red cell ghost membranes. J Cell Biol (1967) 3.96
Selective solubilization of a protein component of the red cell membrane. Science (1968) 3.92
Amino-acid sequence and oligosaccharide attachment sites of human erythrocyte glycophorin. Proc Natl Acad Sci U S A (1975) 3.67
Chemical characterization and surface orientation of the major glycoprotein of the human erythrocyte membrane. Proc Natl Acad Sci U S A (1972) 3.27
The FERM domain: a unique module involved in the linkage of cytoplasmic proteins to the membrane. Trends Biochem Sci (1998) 3.24
Physical and chemical properties of a protein isolated from red cell membranes. Biochemistry (1970) 3.23
Sensitivity of mature Erbb2 to geldanamycin is conferred by its kinase domain and is mediated by the chaperone protein Hsp90. J Biol Chem (2000) 3.06
Primary structure of human erythrocyte glycophorin A. Isolation and characterization of peptides and complete amino acid sequence. Biochemistry (1978) 3.02
Demonstration of the outer surface of freeze-etched red blood cell membranes. J Cell Biol (1970) 3.00
Polyubiquitination and proteasomal degradation of the p185c-erbB-2 receptor protein-tyrosine kinase induced by geldanamycin. J Biol Chem (1996) 3.00
The localization of spectrin on the inner surface of human red blood cell membranes by ferritin-conjugated antibodies. J Cell Biol (1971) 2.96
Disruption of the Raf-1-Hsp90 molecular complex results in destabilization of Raf-1 and loss of Raf-1-Ras association. J Biol Chem (1995) 2.91
The structure of erythrocyte membranes studied by freeze-etching. II. Localization of receptors for phytohemagglutinin and influenza virus to the intramembranous particles. J Exp Med (1972) 2.78
Erythrocyte spectrin is comprised of many homologous triple helical segments. Nature (1984) 2.78
Rapid deubiquitination of nucleosomal histones in human tumor cells caused by proteasome inhibitors and stress response inducers: effects on replication, transcription, translation, and the cellular stress response. Biochemistry (1997) 2.73
Stabilizing infrastructure of cell membranes. Annu Rev Cell Biol (1985) 2.68
The red cell membrane. Annu Rev Biochem (1976) 2.64
Major glycoprotein of the human erythrocyte membrane: evidence for an amphipathic molecular structure. Arch Biochem Biophys (1973) 2.44
Regulation of the association of membrane skeletal protein 4.1 with glycophorin by a polyphosphoinositide. Nature (1985) 2.41
Disruption of hsp90 function results in degradation of the death domain kinase, receptor-interacting protein (RIP), and blockage of tumor necrosis factor-induced nuclear factor-kappaB activation. J Biol Chem (2000) 2.37
Update on Hsp90 inhibitors in clinical trial. Curr Top Med Chem (2009) 2.34
Self-assembly of spectrin oligomers in vitro: a basis for a dynamic cytoskeleton. J Cell Biol (1981) 2.27
The hsp90-related protein TRAP1 is a mitochondrial protein with distinct functional properties. J Biol Chem (2000) 2.24
Mutant conformation of p53 translated in vitro or in vivo requires functional HSP90. Proc Natl Acad Sci U S A (1996) 2.18
Metastasis-associated differences in gene expression in a murine model of osteosarcoma. Cancer Res (2001) 2.10
Novobiocin and related coumarins and depletion of heat shock protein 90-dependent signaling proteins. J Natl Cancer Inst (2000) 2.09
Interactions between protein 4.1 and band 3. An alternative binding site for an element of the membrane skeleton. J Biol Chem (1985) 1.95
p53 inhibits hypoxia-inducible factor-stimulated transcription. J Biol Chem (1998) 1.94
A structural model of human erythrocyte protein 4.1. J Biol Chem (1984) 1.91
Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer. J Med Genet (2005) 1.85
Identification of the functional site of erythrocyte protein 4.1 involved in spectrin-actin associations. J Biol Chem (1986) 1.84
Identification of functional domains of human erythrocyte spectrin. Proc Natl Acad Sci U S A (1980) 1.82
Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer. Clin Cancer Res (1996) 1.82
Red cell membrane glycoprotein: amino acid sequence of an intramembranous region. Biochem Biophys Res Commun (1972) 1.80
Subunit structure of human erythrocyte glycophorin A. Biochemistry (1976) 1.75
The complete cDNA and polypeptide sequences of human erythroid alpha-spectrin. J Biol Chem (1990) 1.71
p185erbB2 binds to GRP94 in vivo. Dissociation of the p185erbB2/GRP94 heterocomplex by benzoquinone ansamycins precedes depletion of p185erbB2. J Biol Chem (1996) 1.70
The red cell membrane skeleton: recent progress. Blood (1983) 1.70
Evidence that spectrin binds to macromolecular complexes on the inner surface of the red cell membrane. J Cell Sci (1980) 1.68
Identification of proteolytically resistant domains of human erythrocyte spectrin. Proc Natl Acad Sci U S A (1980) 1.66
Selective expression of an erythroid-specific isoform of protein 4.1. Proc Natl Acad Sci U S A (1988) 1.63
Destabilization of Raf-1 by geldanamycin leads to disruption of the Raf-1-MEK-mitogen-activated protein kinase signalling pathway. Mol Cell Biol (1996) 1.61
Full-length sequence of the cDNA for human erythroid beta-spectrin. J Biol Chem (1990) 1.59
Effectiveness of endoscopic ultrasonography in the diagnosis of choledocholithiasis prior to laparoscopic cholecystectomy. Endoscopy (1995) 1.57
Heterogeneity of mRNA and protein products arising from the protein 4.1 gene in erythroid and nonerythroid tissues. J Cell Biol (1990) 1.56
Raf-1/bcl-2 phosphorylation: a step from microtubule damage to cell death. Cancer Res (1997) 1.56
Synthetic peptides mimic the assembly of transmembrane glycoproteins. J Biol Chem (1989) 1.52
Differentiation of pancreatic epithelial progenitor cells into hepatocytes following transplantation into rat liver. Proc Natl Acad Sci U S A (1997) 1.51
Immunological quantitation of thymidylate synthase using the monoclonal antibody TS 106 in 5-fluorouracil-sensitive and -resistant human cancer cell lines. Cancer Res (1992) 1.50
Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway. Cancer Res (1996) 1.48
A small molecule cell-impermeant Hsp90 antagonist inhibits tumor cell motility and invasion. Oncogene (2007) 1.48
Structural changes in membranes of transformed lymphocytes demonstrated by freeze-etching. Cell Immunol (1972) 1.47
Cloning of a portion of the chromosomal gene for human erythrocyte alpha-spectrin by using a synthetic gene fragment. Proc Natl Acad Sci U S A (1986) 1.45
A structural model of human erythrocyte spectrin. Alignment of chemical and functional domains. J Biol Chem (1982) 1.44
Hypoxia-inducible factor-1 (HIF-1) up-regulates adrenomedullin expression in human tumor cell lines during oxygen deprivation: a possible promotion mechanism of carcinogenesis. Mol Endocrinol (2000) 1.41
Molecular and functional changes in spectrin from patients with hereditary pyropoikilocytosis. J Clin Invest (1983) 1.39
A recombinant adenovirus expressing p27Kip1 induces cell cycle arrest and loss of cyclin-Cdk activity in human breast cancer cells. Oncogene (1997) 1.36
Studies on the major sialoglycoprotein of the human red cell membrane. Isolation and characterization of tryptic glycopeptides. Biochemistry (1973) 1.35
Structure of the spectrin-actin binding site of erythrocyte protein 4.1. J Biol Chem (1986) 1.33
A nonerythroid isoform of protein 4.1R interacts with the nuclear mitotic apparatus (NuMA) protein. J Cell Biol (1999) 1.32
A comparative study of spectrin: a protein isolated from red blood cell membranes. Biochim Biophys Acta (1970) 1.30
Functional proteins of the human red blood cell membrane. Semin Hematol (1979) 1.28
Isolation of spectrin from erythrocyte membranes. Methods Enzymol (1974) 1.28
Geldanamycin abrogates ErbB2 association with proteasome-resistant beta-catenin in melanoma cells, increases beta-catenin-E-cadherin association, and decreases beta-catenin-sensitive transcription. Cancer Res (2001) 1.27
HIF and fumarate hydratase in renal cancer. Br J Cancer (2007) 1.27
The binding of vimentin to human erythrocyte membranes: a model system for the study of intermediate filament-membrane interactions. J Cell Biol (1985) 1.27
Protease inhibitor-induced apoptosis: accumulation of wt p53, p21WAF1/CIP1, and induction of apoptosis are independent markers of proteasome inhibition. Leukemia (2000) 1.24
Human monoclonal antibody directed against an envelope glycoprotein of human T-cell leukemia virus type I. Proc Natl Acad Sci U S A (1986) 1.24
A mutant deubiquitinating enzyme (Ubp-M) associates with mitotic chromosomes and blocks cell division. Proc Natl Acad Sci U S A (1999) 1.23
Mutant forms of spectrin alpha-subunits in hereditary elliptocytosis. J Clin Invest (1987) 1.22
Viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus binds to p53 and represses p53-dependent transcription and apoptosis. J Virol (2001) 1.21
Randomized clinical trial: efficacy and safety of telbivudine and lamivudine in treatment-naïve patients with HBV-related decompensated cirrhosis. J Viral Hepat (2012) 1.21
Spectrin: present status of a putative cyto-skeletal protein of the red cell membrane. J Membr Biol (1979) 1.21
Taxol induction of p21WAF1 and p53 requires c-raf-1. Cancer Res (1995) 1.20
Site specificity in vimentin-membrane interactions: intermediate filament subunits associate with the plasma membrane via their head domains. J Cell Biol (1985) 1.20
Molecular features of the major glycoprotein of the human erythrocyte membrane. Fed Proc (1973) 1.20
A murine cDNA encodes a pan-epithelial glycoprotein that is also expressed on plasma cells. J Immunol (1992) 1.19
Fractionation of the major sialoglycopeptides of the human red blood cell membrane. Biochem Biophys Res Commun (1975) 1.18
Five-lipoxygenase inhibitors can mediate apoptosis in human breast cancer cell lines through complex eicosanoid interactions. FASEB J (2001) 1.17
Geldanamycin selectively destabilizes and conformationally alters mutated p53. Oncogene (1995) 1.16
Genomic structure of the locus encoding protein 4.1. Structural basis for complex combinational patterns of tissue-specific alternative RNA splicing. J Biol Chem (1993) 1.16
Geldanamycin-stimulated destabilization of mutated p53 is mediated by the proteasome in vivo. Oncogene (1997) 1.14
Immunochemical evidence for the transmembrane orientation of glycophorin A. Localization of ferritin-antibody conjugates in intact cells. J Mol Biol (1977) 1.12
The measurement of ubiquitin and ubiquitinated proteins. Electrophoresis (1999) 1.10
Sequence and exon-intron organization of the DNA encoding the alpha I domain of human spectrin. Application to the study of mutations causing hereditary elliptocytosis. J Clin Invest (1989) 1.08
Molecular cloning of the cDNA for human erythrocyte beta-spectrin. Blood (1988) 1.08
The structural basis of ankyrin function. II. Identification of two functional domains. J Biol Chem (1984) 1.07
Isolation of membrane glycoproteins by affinity chromatography in the presence of detergents. Biochim Biophys Acta (1976) 1.06
Isolation and characterization of peptides derived from the cytoplasmic segment of band 3, the predominant intrinsic membrane protein of the human erythrocyte. J Biol Chem (1978) 1.06
A structural protein extracted from the trichocyst of Paramecium aurelia. Exp Cell Res (1969) 1.06
Structure of human erythrocyte spectrin. II. The sequence of the alpha-I domain. J Biol Chem (1983) 1.05
Isolation of spectrin subunits and reassociation in vitro. Analysis by fluorescence polarization. J Biol Chem (1984) 1.05
The distribution of spectrin along the membranes of normal and echinocytic human erythrocytes. J Cell Sci (1978) 1.05